U.K. competition watchdog targets pharma for ‘substantial fines’

Emily Wasserman

The 's and Markets Authority (CMA) is planning to levy " " this year, marking a "big step up in the scale and impact" of its enforcement activity, Alex Chisholm, head of the agency, told The Financial Times. And one of those fines will likely be directed at a company, Chisholm said, as the CMA probes drugmakers including GlaxoSmithKline and Pfizer for alleged wrongdoing.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS